The meds are starting to kick-in so I don’t know how much I can share today. But do want you to know I sold 5 shares, 1/2 my BMY position, today. Their QTR was rotten. According to Cramer, a new product due out next year, will be a game changer. We will see. I did keep 5 shares for this In-Case scenario.
Here’s the BMY position with fees included on the summation line:
BMY | 5 | $37.61 | $188.05 |
7/13/2012 | 5 | $34.59 | $172.95 |
9/18/2012 | 5 | $33.00 | $165.00 |
10/24/2012 | -5 | $32.95 | -$164.75 |